SCHEMBL1132359

SCHEMBL1132359

O=C(Cc1ccccc1)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(CO)CS[C@@H]12

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 6/20 0.59
▸ CTDSP1 Q9GZU7 2/20 0.59
▸ MAPK1 P28482 2/20 0.58
▸ MAPT P10636 5/20 0.55
▸ POLB P06746 1/20 0.55
▸ PKM P14618 1/20 0.55
▸ HTT P42858 1/20 0.55
▸ DUSP3 P51452 1/20 0.55
▸ PTPN5 P54829 1/20 0.55
▸ PTPN11 Q06124 1/20 0.55
▸ ALDH1A1 P00352 6/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ PLCG1 P19174 1/20 0.51
▸ PTGS1 P23219 1/20 0.49
▸ CA5A P35218 1/20 0.49
▸ KMT2A Q03164 3/20 0.46
▸ KDM4E B2RXH2 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11015972 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL9099692 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL10579475 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL27275320 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL9642504 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL7804219 1.00 TDP1 (0.59) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL14065427 0.94 TDP1 (0.61) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL8849392 0.93 TDP1 (0.57) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL9699338 0.92 TDP1 (0.58) TDP1CTDSP1MAPK1MAPTPOLB
SCHEMBL11690596 0.92 TDP1 (0.58) TDP1CTDSP1MAPK1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1340762-B1 Cephalosporin synthesis SANDOZ AG (CH) 2011-02-16 — — EP disclosed
EP-1340762-A1 Cephalosporin synthesis BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 2003-09-03 — — EP disclosed
EP-0757691-B1 CEPHALOSPORIN SYNTHESIS BIOCHEMIE GMBH (AT) 2003-07-02 — — EP disclosed
EP-0503453-B1 New process for the production of cephalosporines and novel intermediates in this process BIOCHEMIE GMBH (AT) 2001-05-09 — — EP disclosed
US-6093813-A Cephalosporin compounds BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 2000-07-25 — — US disclosed
US-6063917-A Cephalosporin synthesis BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 2000-05-16 — — US disclosed
US-6034237-A 3-imino-cephalosporins BIOCHEMIE GESELLSCHAFT M.B.H. (AT) 2000-03-07 — — US disclosed
US-5856474-A Cephalosporin synthesis BIOCHEMIE GESELLSCHAFT, M.B.H. (AT) 1999-01-05 — — US disclosed
US-5401841-A Process for the production of cephalosporines SANDOZ LTD. (CH) 1995-03-28 — — US disclosed
US-5171854-A Antibiotics BAYER AKTIENGESELLSCHAFT (DE) 1992-12-15 — — US disclosed
EP-0121244-B1 CEPHALOSPORIN DERIVATIVES Bristol-Myers Company (US) 1990-09-12 — — EP disclosed
EP-0103264-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-12-20 — — EP disclosed
EP-0097961-B1 CEPHALOSPORIN DERIVATIVES, A PROCESS FOR THE MANUFACTURE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES Bristol-Myers Company (US) 1987-11-11 — — EP disclosed
US-4639448-A 7-amino-3-[substituted vinyl]-3-cephem-4-carboxylates having antimicrobial activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-01-27 — — US disclosed
US-4546101-A CEPHALOSPORINS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-10-08 — — US disclosed
US-4493833-A BACTERICIDES, ANTIBIOTICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-01-15 — — US disclosed
EP-0121244-A2 Cephalosporin derivatives Bristol-Myers Company (US) 1984-10-10 — — EP disclosed
EP-0103264-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-03-21 — — EP disclosed
EP-0097961-A2 Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives Bristol-Myers Company (US) 1984-01-11 — — EP disclosed
US-4304770-A Syn-isomer of 3,7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-08 — — US disclosed
Send feedback